Silence Therapeutics PLC

Silence Therapeutics PLC (SLN) Price Prediction & Forecast

$14.740

+1.318 (+8.94%)At close

Price Predictions

1-Day Price Prediction
-0.96%
1-Week Prediction
+0.37%
1-Month Prediction
2026 Prediction
2030 Prediction

Open in app to unlock longer-horizon forecasts.

Loading chart…

SLN Prediction & Forecast by Similar Chart Analysis

Alphio's SLN stock price prediction model matches the current Silence Therapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.60 (-0.96%). The 1-week path is $14.79 (+0.37%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Silence Therapeutics PLC Stock?

Silence Therapeutics PLC is a good buy right now due to its recent positive catalysts, including a successful Phase 2 trial for Divesiran, which showed an 88% response rate in treated patients. The current price of $13.42 is significantly lower than the analyst price target of $32 from Morgan Stanley, indicating a potential upside of 138%. Additionally, the stock has experienced a year-to-date change of +118.21%, reflecting strong momentum. However, investors should be cautious of the company's high net losses, which reached -$12.68 million in Q2 2026, posing a risk to financial stability.

SLN stock price ended at $14.74 on Tuesday, after rising +8.94%

Silence Therapeutics PLC (SLN) last closed at $14.74, gaining +8.94%. These facts feed the 1-day and 1-week SLN price prediction above.

Forecast Drivers

Silence Therapeutics PLC (SLN) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Negative

Bearish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

Similar Chart Patterns

Stocks whose recent price path most closely matches SLN, ranked by similarity.

Seasonality analysis for SLN

Historically the probability of a positive September return for SLN is 23.81%. May offers the highest probability of a positive month at 63.49%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for SLN

MonthMin PriceAvg PriceMax PricePotential ROI
Sep 2026$1.38$2.18$3.10-85.24%
Oct 2026$2.42$3.27$3.33-77.80%
Nov 2026$2.64$3.27$3.33-77.80%
Dec 2026$1.80$2.39$2.94-83.80%

In 2026, Silence Therapeutics PLC (SLN) is projected to range from $1.38 to $3.33.

Silence Therapeutics PLC 2026 monthly forecast

Sep 2026 SLN forecast
Potential ROI: -85.24%

In Sep 2026, Silence Therapeutics PLC is projected to average $2.18, with a low of $1.38 and high of $3.10.

Oct 2026 SLN forecast
Potential ROI: -77.80%

In Oct 2026, Silence Therapeutics PLC is projected to average $3.27, with a low of $2.42 and high of $3.33.

Nov 2026 SLN forecast
Potential ROI: -77.80%

In Nov 2026, Silence Therapeutics PLC is projected to average $3.27, with a low of $2.64 and high of $3.33.

Dec 2026 SLN forecast
Potential ROI: -83.80%

In Dec 2026, Silence Therapeutics PLC is projected to average $2.39, with a low of $1.80 and high of $2.94.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started